Viva Biotech and Adjutor Group have announced a collaboration aimed at expanding their international business networks and strengthening engagement with global life sciences partners.

Under the agreement, the companies will work together to improve market access by providing development, regulatory, clinical and commercialisation services. The partnership is also intended to create new opportunities for collaboration across the biotechnology and pharmaceutical sectors.

The collaboration is expected to extend the reach of Viva Biotech's integrated contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) services, alongside Adjutor Group's regulatory and clinical expertise, to a broader range of research-driven programmes and innovative companies worldwide.

Viva Biotech offers end-to-end services covering the drug development process, from early-stage drug discovery to commercial manufacturing. The company said the partnership supports its strategy of building an open, international and science-focused network of collaborations.

Both companies stated that they will continue to strengthen their global presence by working with partners that share a commitment to advancing innovation and improving access to high-quality research and development services.

 

Source: vivabiotech.com

Report Abuse